Based on the effects of PPARγ on the anti-inflammatory response, in this study we evaluated the antidepressant-like effects of the PPARγ agonist pioglitazone in CMS-induced depression using a mouse model and analyzed the role of M2 microglia in the antidepressant activity of pioglitazone. This evidence concerns the gene PPARG and depressive disorder.